ID: ALA1630014

Max Phase: Preclinical

Molecular Formula: C13H20O3

Molecular Weight: 224.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCC(O)C#CC#C[C@H](O)[C@H](C)O

Standard InChI:  InChI=1S/C13H20O3/c1-3-4-5-8-12(15)9-6-7-10-13(16)11(2)14/h11-16H,3-5,8H2,1-2H3/t11-,12?,13-/m0/s1

Standard InChI Key:  MBEFEDOPHCABIT-RXTYADHFSA-N

Associated Targets(non-human)

Quinone oxidoreductase 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 224.30Molecular Weight (Monoisotopic): 224.1412AlogP: 0.68#Rotatable Bonds: 5
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.41CX Basic pKa: CX LogP: 1.80CX LogD: 1.80
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.48Np Likeness Score: 2.25

References

1. Shin D, Yang JE, Lee SB, Nho CW..  (2010)  SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities.,  20  (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066]

Source